<p>ID8ip2Luc ovarian cancer cells were injected IP into C57BL/6 (WT) or LPP1 KO mice. <b>(A)</b> Mice (WT n = 10; LPP1 KO n = 12) were imaged weekly following tumor initiation to monitor tumor growth. Data represent mean total flux (photons/second) ± std err and were analyzed by 2-way ANOVA followed by Tukey’s multiple comparisons test. <b>(B)</b> The total number of microscopic tumor nodules was counted in an individual, randomly selected, H&E stained section of omentum per mouse obtained 2 weeks after tumor initiation (WT n = 7; LPP1 KO n = 8). Data represent mean ± std err; p = 0.0069 determined by Student’s t-test. <b>(C)</b> The percentage of wild type or LPP1 KO (from <b>(B)</b>) mice with invasive (solid bars) or non-invasive (includ...
<p><b>(A)</b> Concentration of murine OPN (mOPN; ng/ml per 10<sup>6</sup> cells) in 24-hr conditione...
<p><b>A.</b> GFP-expressing NUGC-4 cells (5 ×10<sup>6</sup> cells/mouse) were injected into the peri...
The peritoneum is a common site of dissemination in patients with colorectal cancer. In order to ide...
<p>ID8ip2Luc ovarian cancer cells were injected IP into wild type (WT, n = 19) or LPP1 KO (n = 20) m...
a<p>Each experiment was conducted with tumor tissue derived from a different ovarian cancer patient....
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p>Confidence interval plot of limiting dilution analysis is shown with the y-axis displaying the es...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>(<b>A</b>) Time course of MOPC-21 tumour development. The experimental dose was one that gave 80%...
<p>A, bioluminescence imaging of pharmacologically treated or untreated mice with peritoneal carcino...
<p>(A-D) WT mouse mammary epithelial cells (MMECs), retrovirally transduced with the pMIG-PyMT vecto...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
<p>Tumor growth in <i>PyVT(+/−)/ADN(+/+)</i> and <i>PyVT(+/−)/ADN(+/−)</i> mice were monitored start...
<p>(<b>A</b>) B16-OVA or (<b>B</b>) B16-F10 tumor-bearing mice were treated with PTT then rechalleng...
<div><p>(A) Average number of papillomas (more than 2 mm in diameter) per mouse is plotted versus th...
<p><b>(A)</b> Concentration of murine OPN (mOPN; ng/ml per 10<sup>6</sup> cells) in 24-hr conditione...
<p><b>A.</b> GFP-expressing NUGC-4 cells (5 ×10<sup>6</sup> cells/mouse) were injected into the peri...
The peritoneum is a common site of dissemination in patients with colorectal cancer. In order to ide...
<p>ID8ip2Luc ovarian cancer cells were injected IP into wild type (WT, n = 19) or LPP1 KO (n = 20) m...
a<p>Each experiment was conducted with tumor tissue derived from a different ovarian cancer patient....
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p>Confidence interval plot of limiting dilution analysis is shown with the y-axis displaying the es...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>(<b>A</b>) Time course of MOPC-21 tumour development. The experimental dose was one that gave 80%...
<p>A, bioluminescence imaging of pharmacologically treated or untreated mice with peritoneal carcino...
<p>(A-D) WT mouse mammary epithelial cells (MMECs), retrovirally transduced with the pMIG-PyMT vecto...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
<p>Tumor growth in <i>PyVT(+/−)/ADN(+/+)</i> and <i>PyVT(+/−)/ADN(+/−)</i> mice were monitored start...
<p>(<b>A</b>) B16-OVA or (<b>B</b>) B16-F10 tumor-bearing mice were treated with PTT then rechalleng...
<div><p>(A) Average number of papillomas (more than 2 mm in diameter) per mouse is plotted versus th...
<p><b>(A)</b> Concentration of murine OPN (mOPN; ng/ml per 10<sup>6</sup> cells) in 24-hr conditione...
<p><b>A.</b> GFP-expressing NUGC-4 cells (5 ×10<sup>6</sup> cells/mouse) were injected into the peri...
The peritoneum is a common site of dissemination in patients with colorectal cancer. In order to ide...